Devesh Malik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Devesh Malik has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Kamil F. Faridi
Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA; Center for Outcomes Research and Evaluation, Yale New Haven Health, New Haven, Connecticut, USA
2 shared publications - Mohammed Essa
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA (M.E.).
2 shared publications - Akl C. Fahed
Heart and Vascular Institute, Mass General Brigham
1 shared publication - Daniel Jacobs
Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA
1 shared publication Deepa S. Rajan
Division of Neurology, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, USA
1 shared publicationDennis W. Simon
Department of Critical Care Medicine, UPMC Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh, USA
1 shared publication
Latest Publications
- Open Access
Obesity Endotypes Unmask Heterogeneous Responses to Healthy Lifestyle Behaviors
Background: Lifestyle interventions are central to obesity prevention and management, yet interindividual variability in response remains incompletely understood. Here, we leveraged genetically defined, distinct obesity endotypes to examine lifestyle–body mass index (BMI) associations across biological pathways. Methods: In the UK Biobank, we analyzed 305,713 participants with partitioned polygenic scores (pPSs) representing 10 obesity endotypes. We evaluated interactions between endotype-specific genetic susceptibility and physical activity, diet, sedentary behavior, and sleep on BMI using multivariable linear regression. Primary findings were externally evaluated in the All of Us Research Program using Fitbit-derived lifestyle measures. Results: Favorable lifestyle behaviors were associated with lower BMI for all obesity endotypes, but the magnitude of these associations varied significantly across endotypes. Higher endotype-specific pPSs strengthened the benefits of physical activity (7 endotypes), healthy diet (3 endotypes), nonsedentary behavior (5 endotypes), and adequate sleep (7 endotypes) on BMI. Distinct endotypes demonstrated the greatest responsiveness to different lifestyle domains, with the metabolically unhealthy endotype showing the strongest interaction with physical activity, metabolically healthy endotype with sedentary behavior, hypothalamic dysregulation endotype with diet, and hypoinsulin 2 endotype with sleep, corresponding to differences in BMI of 0.22–0.49 kg/m² between the highest and lowest pPS deciles. These interaction patterns were consistent in the All of Us cohort. Conclusions: Obesity endotypes modify the association between lifestyle behaviors and BMI, demonstrating that responsiveness to lifestyle behaviors is heterogeneous and pathway dependent. These findings provide a framework for precision obesity prevention by identifying individuals who may derive greater benefit from specific lifestyle interventions.
Open AccessObesity Endotypes Unmask Heterogeneous Responses to Healthy Lifestyle Behaviors
Background: Lifestyle interventions are central to obesity prevention and management, yet interindividual variability in response remains incompletely understood. Here, we leveraged genetically defined, distinct obesity endotypes to examine lifestyle–body mass index (BMI) associations across biological pathways. Methods: In the UK Biobank, we analyzed 305,713 participants with partitioned polygenic scores (pPSs) representing 10 obesity endotypes. We evaluated interactions between endotype-specific genetic susceptibility and physical activity, diet, sedentary behavior, and sleep on BMI using multivariable linear regression. Primary findings were externally evaluated in the All of Us Research Program using Fitbit-derived lifestyle measures. Results: Favorable lifestyle behaviors were associated with lower BMI for all obesity endotypes, but the magnitude of these associations varied significantly across endotypes. Higher endotype-specific pPSs strengthened the benefits of physical activity (7 endotypes), healthy diet (3 endotypes), nonsedentary behavior (5 endotypes), and adequate sleep (7 endotypes) on BMI. Distinct endotypes demonstrated the greatest responsiveness to different lifestyle domains, with the metabolically unhealthy endotype showing the strongest interaction with physical activity, metabolically healthy endotype with sedentary behavior, hypothalamic dysregulation endotype with diet, and hypoinsulin 2 endotype with sleep, corresponding to differences in BMI of 0.22–0.49 kg/m² between the highest and lowest pPS deciles. These interaction patterns were consistent in the All of Us cohort. Conclusions: Obesity endotypes modify the association between lifestyle behaviors and BMI, demonstrating that responsiveness to lifestyle behaviors is heterogeneous and pathway dependent. These findings provide a framework for precision obesity prevention by identifying individuals who may derive greater benefit from specific lifestyle interventions.
- Open Access
- 19 June 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 30
Primary prevention statin eligibility for U.S. adults under the 2026 ACC/AHA dyslipidemia guideline
- 19 June 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 30
Open AccessPrimary prevention statin eligibility for U.S. adults under the 2026 ACC/AHA dyslipidemia guideline
- 1 April 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (4) , e26387
Primary Prevention Antihypertensive Eligibility With the 2025 AHA/ACC Guideline
- 1 April 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (4) , e26387
Primary Prevention Antihypertensive Eligibility With the 2025 AHA/ACC Guideline
- 28 February 2026
- Published by Springer Nature in Medical Science Educator
- Vol. 36 (2) , 525-532
Assessing the Impact of an Introductory Medical American Sign Language (ASL) Seminar on the ASL Knowledge and Competence of Healthcare Students
Introduction: There are approximately 50 million people in the US who identify as Deaf or Hard-of-Hearing (HoH), of which 1 million use American Sign Language (ASL) as their primary language. Despite this, many healthcare providers are inexperienced when communicating with Deaf/HoH patients. Methods: We designed and facilitated a workshop to teach introductory medical ASL to healthcare professional students, led by a college Linguistics professor and Deaf/HoH individual. A pre- and post-workshop survey was administered to attendees, which measured their self-reported ASL fluency, confidence in performing ASL gestures, and confidence in initiating healthcare-based interactions with Deaf/HoH patients. Results: Thirteen attendees enrolled in the study, of whom 12 completed both the pre- and post-workshop surveys; 9 were medical students and 4 were physician assistant students. Upon workshop completion, 11/12 reported an improvement in ASL fluency, 10/12 reported an improvement in confidence in properly performing ASL gestures, and 9/12 reported an improvement in confidence in initiating healthcare-based interactions with Deaf/HoH patients. Of those with no prior experience in ASL (10/12 participants), 100% of them reported an improvement in ASL fluency. Discussion: This study is the first to describe the development and implementation of an introductory medical ASL workshop for healthcare students. Our results suggest this style of education has strong potential for raising awareness of the Deaf/HoH patient population and modestly improving self-perceived ASL fluency and confidence of healthcare students. Early education in medical ASL is critical to developing culturally-competent healthcare providers and narrowing the gap in healthcare disparities for Deaf/HoH patients.
- 28 February 2026
- Published by Springer Nature in Medical Science Educator
- Vol. 36 (2) , 525-532
Assessing the Impact of an Introductory Medical American Sign Language (ASL) Seminar on the ASL Knowledge and Competence of Healthcare Students
Introduction: There are approximately 50 million people in the US who identify as Deaf or Hard-of-Hearing (HoH), of which 1 million use American Sign Language (ASL) as their primary language. Despite this, many healthcare providers are inexperienced when communicating with Deaf/HoH patients. Methods: We designed and facilitated a workshop to teach introductory medical ASL to healthcare professional students, led by a college Linguistics professor and Deaf/HoH individual. A pre- and post-workshop survey was administered to attendees, which measured their self-reported ASL fluency, confidence in performing ASL gestures, and confidence in initiating healthcare-based interactions with Deaf/HoH patients. Results: Thirteen attendees enrolled in the study, of whom 12 completed both the pre- and post-workshop surveys; 9 were medical students and 4 were physician assistant students. Upon workshop completion, 11/12 reported an improvement in ASL fluency, 10/12 reported an improvement in confidence in properly performing ASL gestures, and 9/12 reported an improvement in confidence in initiating healthcare-based interactions with Deaf/HoH patients. Of those with no prior experience in ASL (10/12 participants), 100% of them reported an improvement in ASL fluency. Discussion: This study is the first to describe the development and implementation of an introductory medical ASL workshop for healthcare students. Our results suggest this style of education has strong potential for raising awareness of the Deaf/HoH patient population and modestly improving self-perceived ASL fluency and confidence of healthcare students. Early education in medical ASL is critical to developing culturally-competent healthcare providers and narrowing the gap in healthcare disparities for Deaf/HoH patients.
- 27 February 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (8) , 3633-3644
Patterns of Care for T1 Glottic Squamous Cell Carcinomas from 2004–2020
Objective(s): Describe recent national trends in overall treatment modalities for T1 glottic squamous cell carcinomas (SCC), and identify factors associated with treatment regimens.Methods: National Cancer Database from 2004–2020 was queried for all patients with glottic cT1N0M0 SCC. Treatment patterns over time were analyzed using the Cochran‐Armitage test for trend. Multivariable logistic regressions were used to determine the factors associated with treatment regimens.Results: Of the 22,414 patients identified, most patients received RT only (57%), 21% received surgery only, and 22% received dual‐modality treatment (“over‐treatment”). Over the time period, there was a decreasing trend in rates of over‐treatment for T1 glottic SCC (p < 0.001) and an increasing trend in surgery only (p < 0.001). Treatment in 2016–2018 (OR: 1.168 [1.004 to 1.359]), 2013–2015 (OR: 1.419 [1.221 to 1.648]), 2010–2012 (OR: 1.611 [1.388 to 1.871]), 2007–2009 (OR: 1.682 [1.450 to 1.951]), or 2004–2006 (OR: 1.795 [1.548 to 2.081]) versus 2019–2020 was associated with greater likelihood of over‐treatment. T1b tumors were less likely to be over‐treated (OR: 0.795 [0.707 to 0.894]) versus T1a tumors, and less likely to receive surgery first (OR: 0.536 [0.485 to 0.592]) versus T1a tumors.Conclusion: Over‐treatment for T1 glottic SCC has been declining, with increasing rates of surgery only. Year of treatment was significantly associated with the receipt of dual‐modality treatment. Finally, patients with T1b disease were more likely to receive RT as the first and only treatment.Level of Evidence: 3 Laryngoscope, 134:3633–3644, 2024
- 27 February 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (8) , 3633-3644
Patterns of Care for T1 Glottic Squamous Cell Carcinomas from 2004–2020
Objective(s): Describe recent national trends in overall treatment modalities for T1 glottic squamous cell carcinomas (SCC), and identify factors associated with treatment regimens.Methods: National Cancer Database from 2004–2020 was queried for all patients with glottic cT1N0M0 SCC. Treatment patterns over time were analyzed using the Cochran‐Armitage test for trend. Multivariable logistic regressions were used to determine the factors associated with treatment regimens.Results: Of the 22,414 patients identified, most patients received RT only (57%), 21% received surgery only, and 22% received dual‐modality treatment (“over‐treatment”). Over the time period, there was a decreasing trend in rates of over‐treatment for T1 glottic SCC (p < 0.001) and an increasing trend in surgery only (p < 0.001). Treatment in 2016–2018 (OR: 1.168 [1.004 to 1.359]), 2013–2015 (OR: 1.419 [1.221 to 1.648]), 2010–2012 (OR: 1.611 [1.388 to 1.871]), 2007–2009 (OR: 1.682 [1.450 to 1.951]), or 2004–2006 (OR: 1.795 [1.548 to 2.081]) versus 2019–2020 was associated with greater likelihood of over‐treatment. T1b tumors were less likely to be over‐treated (OR: 0.795 [0.707 to 0.894]) versus T1a tumors, and less likely to receive surgery first (OR: 0.536 [0.485 to 0.592]) versus T1a tumors.Conclusion: Over‐treatment for T1 glottic SCC has been declining, with increasing rates of surgery only. Year of treatment was significantly associated with the receipt of dual‐modality treatment. Finally, patients with T1b disease were more likely to receive RT as the first and only treatment.Level of Evidence: 3 Laryngoscope, 134:3633–3644, 2024
- 5 October 2022
- Published by Springer Nature in Genes & Immunity
- Vol. 23 (7) , 235-239
Genetic variation in genes of inborn errors of immunity in children with unexplained encephalitis
Pediatric encephalitis has significant morbidity and mortality, yet 50% of cases are unexplained. Host genetics plays a role in encephalitis’ development; however, the contributing variants are poorly understood. One child with anti-NMDA receptor encephalitis and ten with unexplained encephalitis underwent whole genome sequencing to identify rare candidate variants in genes known to cause monogenic immunologic and neurologic disorders, and polymorphisms associated with increased disease risk. Using the professional Human Genetic Mutation Database (Qiagen), we divided the candidate variants into three categories: monogenic deleterious or potentially deleterious variants (1) in a disease-consistent inheritance pattern; (2) in carrier states; and (3) disease-related polymorphisms. Six patients (55%) had a deleterious or potentially deleterious variant in a disease-consistent inheritance pattern, five (45%) were heterozygous carriers for an autosomal recessive condition, and six (55%) carried a disease-related polymorphism. Finally, seven (64%) had more than one variant, suggesting possible polygenetic risk. Among variants identified were those implicated in atypical hemolytic uremic syndrome, common variable immunodeficiency, hemophagocytic lymphohistiocytosis, and systemic lupus erythematosus. This preliminary study shows genetic variation related to inborn errors of immunity in acute pediatric encephalitis. Future research is needed to determine if these variants play a functional role in the development of unexplained encephalitis.
- 5 October 2022
- Published by Springer Nature in Genes & Immunity
- Vol. 23 (7) , 235-239
Genetic variation in genes of inborn errors of immunity in children with unexplained encephalitis
Pediatric encephalitis has significant morbidity and mortality, yet 50% of cases are unexplained. Host genetics plays a role in encephalitis’ development; however, the contributing variants are poorly understood. One child with anti-NMDA receptor encephalitis and ten with unexplained encephalitis underwent whole genome sequencing to identify rare candidate variants in genes known to cause monogenic immunologic and neurologic disorders, and polymorphisms associated with increased disease risk. Using the professional Human Genetic Mutation Database (Qiagen), we divided the candidate variants into three categories: monogenic deleterious or potentially deleterious variants (1) in a disease-consistent inheritance pattern; (2) in carrier states; and (3) disease-related polymorphisms. Six patients (55%) had a deleterious or potentially deleterious variant in a disease-consistent inheritance pattern, five (45%) were heterozygous carriers for an autosomal recessive condition, and six (55%) carried a disease-related polymorphism. Finally, seven (64%) had more than one variant, suggesting possible polygenetic risk. Among variants identified were those implicated in atypical hemolytic uremic syndrome, common variable immunodeficiency, hemophagocytic lymphohistiocytosis, and systemic lupus erythematosus. This preliminary study shows genetic variation related to inborn errors of immunity in acute pediatric encephalitis. Future research is needed to determine if these variants play a functional role in the development of unexplained encephalitis.